Home > About VHIO > Research Support Services > Organization
Organization
Transition for faster translation: VHIO´s scientific structure reorganized
As a direct reflection of exciting growth coupled with increased scientific output of excellence, VHIO is pleased to announce a new scientific structure which has been specifically engineered to deliver on the next essential phase of expansion and the reinforcement of its purely translational research model.
Previously scientific activity was organized as two major programs - clinical and basic research - incorporating several groups, each led by respective Principle Investigators (PIs). Scientific activity at VHIO is now structured across four major programs: Preclinical Research, Translational Research, Clinical Research and Core Technologies.
Read more:
Click here to view VHIO's organizational chart
Executive Board
It includes the Scientific Director, the Preclinical Research Director, the Translational Research Director, the Clinical Research Director; and the Managing Director.
- José Baselga, MD, Scientific Director
- Josep Tabernero, MD, Clinical Research Director
- Joaquín Arribas, PhD, ICREA, Preclinical Research Director
- Joan Seoane, PhD, ICREA, Translational Research Director
- Andrés de Kelety, Managing Director
In general terms the Executive Board is responsible for all structural or scientific matters of general interest and executing the recommendations of other bodies.
Main functions:
- Coordination and strategic planning of research and knowledge transfer of the institute
- Driving the research programs
- Monitoring and coordination of the execution of scientific activity, the center’s strategic plan and the annual plan of activities
- Promotion and development of the scientific community and its constituent members
- Discussion and preparation of the proposals to be approved by other governing bodies
Research Support Services
The Research Support Services are organized into professionally specialized functional areas.
Research Commission
The Research Commission is made up of the Scientific Director, the Preclinical Research Director, the Clinical Research Director and the Translational Research Director. The Managing Director and the R&d Office Manager are present as non-voting advisors.
